APA

Schoedel K. A., Sun H., Sellers E. M., Faulknor J., Levy-Cooperman N., Li X., Kennedy W. P., Cha J., Lewis N. M., Liu W., Bondiskey P., McCrea J. B., Panebianco D. L., Troyer M. D. & Wagner J. A. (20170412). Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study. : Journal of clinical psychopharmacology.

Chicago

Schoedel Kerri A, Sun Hong, Sellers Edward M, Faulknor Janice, Levy-Cooperman Naama, Li Xiaodong, Kennedy William P, Cha Jang-Ho, Lewis Nicole M, Liu Wen, Bondiskey Phung, McCrea Jacqueline B, Panebianco Deborah L, Troyer Matthew D and Wagner John A. 20170412. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study. : Journal of clinical psychopharmacology.

Harvard

Schoedel K. A., Sun H., Sellers E. M., Faulknor J., Levy-Cooperman N., Li X., Kennedy W. P., Cha J., Lewis N. M., Liu W., Bondiskey P., McCrea J. B., Panebianco D. L., Troyer M. D. and Wagner J. A. (20170412). Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study. : Journal of clinical psychopharmacology.

MLA

Schoedel Kerri A, Sun Hong, Sellers Edward M, Faulknor Janice, Levy-Cooperman Naama, Li Xiaodong, Kennedy William P, Cha Jang-Ho, Lewis Nicole M, Liu Wen, Bondiskey Phung, McCrea Jacqueline B, Panebianco Deborah L, Troyer Matthew D and Wagner John A. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study. : Journal of clinical psychopharmacology. 20170412.